Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ipca Expands to U.S. Market | Contract Pharma

What are you searching for?

Sign in
Breaking News

Ipca Expands to U.S. Market

Acquires North Carolina-based CMO Pisgah Labs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Indian pharmaceutical company, Ipca Laboratories, through two of its subsidiaries—Ipca Pharmaceuticals Inc USA and Onyx Scientific Ltd.—has acquired a NC-based contract manufacturing organization (CMO), Pisgah Labs, for $9.65 millions.

Pisgah Labs started operations in 1981 as a contract manufacturer and developer of active pharmaceutical ingredients (APls) and intermediates. It will continue to operate out of its North Carolina manufacturing facility under the Pisgah trade name.

According to Ipca, Onyx and Pisgah’s capabilities in chemistry services will dovetail effectively with its capabilities in supporting Phase II to commercial scale programs and also enable the company to manufacture small volume APls for the U.S. market.

Ipca bought Onyx back in 2011, which was its first move outside India.

In 2017 Pisgah had a total income of $2.89 millions and EBIDTA of $1.14 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics